title: A widely available method for the assessment of aerosol delivery in cystic fibrosis.
abstract: Whilst nebulisers are commonly used in the treatment of cystic fibrosis (CF), nebulised aerosol lung deposition in individual patients is not routinely assessed in clinical practice. The present study was designed to evaluate whether a comparative measurement of aerosol lung deposition from nebulisers using a widely available scintigraphic method could be employed to assist the selection of the best system for individual patients. Lung deposition of the radiolabelled aerosol from the Pari LC Plus (Pari Medical Ltd) nebuliser and the HaloLite Adaptive Aerosol Delivery (AAD) system (Profile Therapeutics Ltd) was measured using planar scintigraphy in 10 healthy volunteers and 6 CF patients. The HaloLite AAD delivered on average 2.1 times (P=0.003) as much aerosol to the lungs compared with Pari LC Plus. Only two subjects had higher lung deposition from Pari LC Plus than HaloLite AAD system. There was marked inter-individual variation in the deposition pattern in CF patients. The aerosol deposition from HaloLite AAD had higher central distribution than that obtained with the Pari LC Plus. The overall intersubject variability of the delivered dose was 56% with Pari LC Plus and 24% with HaloLite AAD (P<0.05). The measurement of aerosol deposition from nebulisers can be performed using a simple and widely available methodology, and may improve nebuliser selection in CF patients.
authors.affiliation: Academic Department of Respiratory Medicine, University of Hull, Castle Hill Hospital, Castle Road, Cottingham, East Yorkshire HU16 5JQ, UK.
authors.forename: Jack A
authors.initials: JA
authors.lastname: Kastelik
authors.forename: Graham A
authors.initials: GA
authors.lastname: Wright
authors.forename: Imran
authors.initials: I
authors.lastname: Aziz
authors.forename: Mal
authors.initials: M
authors.lastname: Davies
authors.forename: Gerard R
authors.initials: GR
authors.lastname: Avery
authors.forename: Alex J
authors.initials: AJ
authors.lastname: Paddon
authors.forename: Sydney
authors.initials: S
authors.lastname: Howey
authors.forename: Alyn H
authors.initials: AH
authors.lastname: Morice
mesh_terms: D000328:Adult; D000336:Aerosols / Q000008:administration & dosage* / Q000493:pharmacokinetics; D003550:Cystic Fibrosis / Q000000981:diagnostic imaging / Q000188:drug therapy*; D005260:Female; D006801:Humans; D008168:Lung / Q000000981:diagnostic imaging / Q000378:metabolism; D008297:Male; D009330:Nebulizers and Vaporizers; D011877:Radionuclide Imaging
chemical_list: D000336:Aerosols